Pregnancy outcomes in patients treated with bosutinib

AIM: Preclinical studies have shown reproductive toxicity with bosutinib, but little is known about its effects during conception or pregnancy in humans. METHODS: Pregnancy cases in patients receiving bosutinib were identified from the Pfizer safety database. RESULTS: Thirty-three pregnancy reports...

Descripción completa

Detalles Bibliográficos
Autores principales: Cortes, Jorge E, Gambacorti-Passerini, Carlo, Deininger, Michael, Abruzzese, Elisabetta, DeAnnuntis, Liza, Brümmendorf, Tim H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510513/
https://www.ncbi.nlm.nih.gov/pubmed/33005329
http://dx.doi.org/10.2217/ijh-2020-0004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510513/
https://www.ncbi.nlm.nih.gov/pubmed/33005329
http://dx.doi.org/10.2217/ijh-2020-0004

Ejemplares similares